Related Experiment Video

Updated: Apr 25, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

13.1K

Pro-survival role of MITF in melanoma

Mariusz L Hartman1, Malgorzata Czyz1

  • 1Department of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.

The Journal of Investigative Dermatology
|August 22, 2014
PubMed

Insights

Microphthalmia-associated transcription factor (MITF) drives survival in therapy-resistant melanoma. This review discusses MITF's pro-survival role and its regulation in melanoma treatment.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Melanoma exhibits therapy resistance due to robust cell survival mechanisms.
  • While some cytoprotective components are common in tumors, specific regulators are unique to melanoma.
  • Microphthalmia-associated transcription factor (MITF) is a key regulator of melanoma survival.

Purpose of the Study:

  • To review the pro-survival functions of MITF in melanoma.
  • To explore the role of MITF as a lineage addiction oncogene.
  • To discuss the interplay between MITF and other melanoma-associated proteins.

Main Methods:

  • Literature review focusing on MITF's role in melanoma.
  • Analysis of gene expression and protein interactions related to MITF.
  • Discussion of regulatory pathways influencing MITF activity.

Main Results:

  • MITF directly targets genes that promote cell survival in melanoma.
  • MITF acts as a lineage addiction oncogene, crucial for melanoma cell identity and survival.
  • BRAF(V600E) and other deregulated proteins modulate MITF activity and function.

Conclusions:

  • MITF is a central mediator of pro-survival signaling in melanoma.
  • Understanding MITF's regulation is critical for developing effective melanoma therapies.
  • MITF's interaction with other oncogenic proteins highlights its significance in melanoma pathogenesis and treatment resistance.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K